tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Market Movers
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

TAK Stock Latest News

Takeda Announces Share Repurchase Plan for 2025
Company AnnouncementsTakeda Announces Share Repurchase Plan for 2025
8d ago
6K
TAK
Takeda CEO Christophe Weber to retire in 2026, Julie Kim to succeed
PremiumThe Fly
Takeda CEO Christophe Weber to retire in 2026, Julie Kim to succeed
22d ago
TAK
Takeda’s Earnings Call Reveals Mixed Performance, Optimistic Outlook
PremiumCompany Announcements
Takeda’s Earnings Call Reveals Mixed Performance, Optimistic Outlook
23d ago
TAK
Vivek Ramaswamy’s Net Worth – The Youngest Billionaire Republican Presidential Candidate
PremiumMarket News
Vivek Ramaswamy’s Net Worth – The Youngest Billionaire Republican Presidential Candidate
23d ago
RUM
TAK
TAK Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
TAK Upcoming Earnings Report: What to Expect?
24d ago
TAK
Neurocrine announces amendment to collaboration with Takeda
PremiumThe FlyNeurocrine announces amendment to collaboration with Takeda
25d ago
TAK
NBIX
Avadel names Sev Melkonian as VP, patient services, distribution, reimbursement
Premium
The Fly
Avadel names Sev Melkonian as VP, patient services, distribution, reimbursement
30d ago
TAK
AVDL
Keros Therapeutics announces effectiveness of global agreement with Takeda
Premium
The Fly
Keros Therapeutics announces effectiveness of global agreement with Takeda
1M ago
TAK
KROS
Keros Therapeutics price target lowered to $41 from $44 at Scotiabank
PremiumThe Fly
Keros Therapeutics price target lowered to $41 from $44 at Scotiabank
1M ago
TAK
KROS
Halozyme announces Takeda receives approval for HYQVIA by MHLW
PremiumThe Fly
Halozyme announces Takeda receives approval for HYQVIA by MHLW
2M ago
TAK
HALO
Takeda announces Japan MHLW approval for new Hyqvia use
PremiumThe Fly
Takeda announces Japan MHLW approval for new Hyqvia use
2M ago
TAK
Keros Therapeutics price target lowered to $43 from $100 at Truist
PremiumThe Fly
Keros Therapeutics price target lowered to $43 from $100 at Truist
2M ago
TAK
KROS
Takeda Announces Subsidiary Liquidation and Merger Completion
PremiumCompany AnnouncementsTakeda Announces Subsidiary Liquidation and Merger Completion
2M ago
6K
TAK
Hutchmed to receive milestone payment from Takeda
Premium
The Fly
Hutchmed to receive milestone payment from Takeda
2M ago
HCM
TAK
Takeda, Keros Therapeutics enter exclusive elritercept license agreement
Premium
The Fly
Takeda, Keros Therapeutics enter exclusive elritercept license agreement
3M ago
TAK
KROS
Keros Therapeutics announces global license agreement with Takeda
PremiumThe Fly
Keros Therapeutics announces global license agreement with Takeda
3M ago
TAK
KROS
Takeda’s Strong FY2024 H1 Boosts Full-Year Outlook
PremiumCompany Announcements
Takeda’s Strong FY2024 H1 Boosts Full-Year Outlook
3M ago
6K
TAK
Hutchmed to receive milestone payment following Takeda launch of Fruzaqla
PremiumThe Fly
Hutchmed to receive milestone payment following Takeda launch of Fruzaqla
3M ago
HCM
TAK
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
4M ago
RDY
TAK
Stifel bullish on orexin, upgrades Alkermes to Buy
PremiumThe FlyStifel bullish on orexin, upgrades Alkermes to Buy
4M ago
TAK
ALKS
Takeda Pharmaceutical Announces Robust Earnings Growth
Premium
Company Announcements
Takeda Pharmaceutical Announces Robust Earnings Growth
4M ago
TAK
Hutchmed to receive $20M milestone payment from Takeda for Fruzaqla sales
Premium
The Fly
Hutchmed to receive $20M milestone payment from Takeda for Fruzaqla sales
4M ago
HCM
TAK

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >